Jiangwen Yin

Jiangwen Yin


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

22 February 2023 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
TLTielong Liu
Tielong Liu
RWRuixue Wang
Ruixue Wang
WQWenqiang Qi
Wenqiang Qi
LJLei Jia
Lei Jia
KMKetao Ma
Ketao Ma
JYJiangwen Yin
Jiangwen Yin

30 June 2023 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
JZJingwen Zhai
Jingwen Zhai
NLNian Li
Nian Li
XZXu Zhang
Xu Zhang
YLYan Li
Yan Li
KMKetao Ma
Ketao Ma
SWSheng Wang
Sheng Wang

16 June 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
CZChengchao Zhang
Chengchao Zhang
XQXinlei Qin
Xinlei Qin
WZWenyi Zhou
Wenyi Zhou
SHShuaijie He
Shuaijie He
ALAo Liu
Ao Liu
JYJiangwen Yin
Jiangwen Yin
Background: Currently, there is no uniform standard for selecting the left double lumen tubes (LDLT). Advantages, such as safety and convenience of the ultrasonic technology, and measurement accuracy, make it more widely applied in the clinical anesthesia, and computed tomography (CT) multi-planar reconstruction (MPR) technology will certainly provide a more accurate measurement. For better application for thoracic surgery choice LDLT, relieving the injury to patients, and reducing the complications, this study will compare the two approaches.Methods: The first part, 120 cases of patients were selected according to the height and gender; recording the patient's optimum LDLT and measurement the transverse diameter of the cricoid cartilage (TD-C) by ultrasound and CT MPR, and then obtained the TD-C range measurement by ultrasound and CT MPR corresponding to different types of LDLT. The second part, total of 102 patients were divided into the ultrasound group and the CT MPR group. In the ultrasound group, TD-C was measured by ultrasound, the corresponding size for intubation was selected based on the conclusions derived from the first part. In the CT MPR group, TD-C was measured by CT MPR, the corresponding size of LDLT based on the conclusions derived from the first part.Results: In the first part, 120 patients were no significant difference in the basic characteristics (P > 0.05). The accuracy of selecting the LDLT by conventional experience, namely height and gender was 58.3%. Ultrasonic measurement TD-C range was as follows: 32 Fr 17.80. CT MPR measurement TD-C range was as follows: 32 Fr 17.65. In the second part, there was no significant difference in the basic characteristics between the two groups (P > 0.05). The accuracy of intubation in the ultrasound group was 90.2% and the corresponding in the CT MPR group was 94.1% (P > 0.05).Conclusions: The accuracy of selecting the LDLT based on TD-C is significantly higher than conventional experience; it can significantly reduce the post-operative complications and there was no statistical significance in the accuracy of LDLT selected for TD-C measurement by ultrasound vs. CT, and both of them could be safely used for the evaluation before intubation under anesthesia in thoracic surgery.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JYJiangwen Yin
Jiangwen Yin
XLXuejiao Liu
Xuejiao Liu
RWRuixue Wang
Ruixue Wang
MGMingyue Ge
Mingyue Ge
LXLiping Xie
Liping Xie
SWSheng Wang
Sheng Wang
Aim. Connexin 43 (Cx43) has been identified to be important for cerebral ischemia/reperfusion (I/R) injury as well as protection from it. This study was aimed at investigating the relationship between phosphorylated Cx43 (p‐Cx43), transforming growth factor‐β1 (TGF‐β1)/Smad2/3 signaling pathway, and isoflurane postconditioning (ISPOC), which has effects on brain injury in rats with cerebral ischemia/reperfusion (I/R) injury. Methods. The middle cerebral artery occlusion (MCAO) model was induced in 96 male Sprague‐Dawley rats, weighing 250‐300 g. The rats were randomized into 12 groups, namely, sham, middle cerebral artery occlusion (MCAO)/I/R, I/R+1.5% ISPOC, I/R+LY2157299 (blocker of TGF‐β1), I/R+LY2157299+1.5% ISPOC, I/R+Ro318220 (inhibitor of p‐Cx43), I/R+Ro318220+1.5% ISPOC, I/R+18β‐GA (activator of p‐Cx43), I/R+18β‐GA+1.5% ISPOC, I/R+1.5%ISPOC+LY2157299+Ro318220, dimethyl sulfoxide (DMSO), and 1.5% ISPOC+DMSO. The protective effect of 1.5% ISPOC was tested by neurological deficit scoring and 2,3,5‐triphenyl tetrazolium chloride staining (TTC staining). The terminal deoxynucleotidyl transferase‐mediated dUTP nick‐end labeling (TUNEL) method and hematoxylin‐eosin (HE) staining were used to observe apoptosis of CA1 cells in the hippocampus. The function of protein synthesis in neurons was tested by Nissl staining. Expression levels of TGF‐β1, Smad2/3, phosphorylated Smad2/3 (p‐Smad2/3), Cx43, and phosphorylated Cx43 (p‐Cx43) were measured by Western blot, immunofluorescence (IF), and quantitative real‐time polymerase chain reaction (qRT‐PCR). Results. Neurological deficit scores, brain infarct volume, and damaged neurons in the I/R group significantly increased compared to those in the sham group (P < 0.05). However, in the ISPOC group, damage of the brain was significantly ameliorated (P < 0.05). qRT‐PCR showed more p‐Cx43 mRNA expression in the hippocampal tissue of the ISPOC group than of the I/R group (P < 0.05). Western blot and immunofluorescence results showed similar changes in p‐Cx43 protein levels of both groups. The expression levels of related proteins (TGF‐β1 and p‐Smad2/3) both increased in the ISPOC group (P < 0.05), whereas total Smad2/3 and total Cx43 expression did not change in all groups. However, when a TGF‐β1 inhibitor (LY2157299) was applied, expression levels of p‐Cx43 significantly decreased as well as neuronal density (P < 0.05). By contrast, expression levels of TGF‐β1 did not change significantly after the application of a p‐Cx43 inhibitor (Ro318220) or the p‐Cx43 activator 18β‐GA (P > 0.05). Conclusion. Isoflurane postconditioning (ISPOC) may alleviate cerebral I/R injury through upregulating the expression of p‐Cx43, and the TGF‐β1/Smad2/3 signaling pathway may be involved in the process.

14 April 2023 in Oncology Research and Treatment
Verified
Journal Article
Closed access
PDF file
XZXiangxin Zhang
Xiangxin Zhang
LYliu yang
liu yang
BHBing Huang
Bing Huang
JYJiangwen Yin
Jiangwen Yin
YWYutao Wei
Yutao Wei
Introduction: Small cell lung cancer (SCLC) is a special type of lung cancer sensitive to radiotherapy and chemotherapy but is prone to drug resistance and recurrence and has a very poor prognosis. This study aimed to explore the potential biomarkers and therapeutic targets for SCLC. Methods: After batch normalization of GSE40275, GSE1037, and GSE44447 datasets, R was used to screen SCLC’s differentially expressed genes (DEGs) and hub genes. We used immunohistochemistry (IHC) to assess the tissue’s expression level of the hub gene. The clinical value of the hub gene was further evaluated based on the collected clinical-pathological data. Results: In this study, a total of 230 DEGs (133 upregulated and 97 downregulated) were screened by the R package. The IHC showed that the expression of CCNA2 and CCNE2 in SCLC tissues was significantly higher than that in normal tissues (p < 0.01). Overexpression of CCNA2 was closely associated with the extensive period of NCCN (p = 0.004), tumor position (p = 0.046), and clinical stage (p = 0.002). The high expression levels of CCNE2 were related to high survival in chemotherapy patients (p = 0.019). Conclusion: CCNA2 and CCNE2 may serve as potential biomarkers of diagnosis and treatment for SCLC.